Chaudry M. Mushtaq, MD | Authors

NSLIJ PLAINVIEW HOSPITAL PHARM

888 OLD COUNTRY RD

Articles

Irinotecan in the Management of Patients With Pancreatic Cancer

December 03, 2000

Synergy with no overlapping toxicities has been demonstrated for the combination of irinotecan ( Camptosar, CPT-11) and gemcitabine (Gemzar) in vitro. Results of a single-institution phase I study in which patients with